Nomograms for Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection

被引:220
|
作者
Yang, Hwai-I
Sherman, Morris
Su, Jun
Chen, Pei-Jer
Liaw, Yun-Fan
Iloeje, Uchenna H.
Chen, Chien-Jen [1 ]
机构
[1] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan
关键词
LIVER FIBROSIS; BIOCHEMICAL MARKERS; HEART-DISEASE; PREDICTION; CIRRHOSIS; SCORE; PREVENTION; GENOTYPE; MODELS; LEVEL;
D O I
10.1200/JCO.2009.27.4456
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Counseling patients with chronic hepatitis B virus (HBV) on their individual risk of liver disease progression is challenging. This study aimed to develop nomograms for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B. Patients and Methods Two thirds of the Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer Hepatitis B Virus (REVEAL-HBV) study cohort was allocated for model derivation (n = 2,435), and the remaining third was allocated for model validation (n = 1,218). Previously confirmed independent risk predictors included in three Cox proportional hazards regression models were sex, age, family history of hepatocellular carcinoma, alcohol consumption habit, serum ALT level, hepatitis B envelope antigen (HBeAg) serostatus, serum HBV DNA level, and HBV genotype. Regression coefficients were rounded into integer risk scores, and predicted risk over 5- and 10-year periods for each risk score was calculated and depicted in nomograms. The predictive accuracy was evaluated using the area under the receiver operating characteristic curve (AUROC) and the correlation between predicted and observed hepatocellular carcinoma risk. Results All selected risk predictors were statistically significant in all models. In each model, either HBeAg seropositivity or HBeAg seronegativity with high viral load (HBV DNA level >= 100,000 copies/mL) and genotype C infection had the highest risk scores. All AUROCs for risk prediction nomogram were >= 0.82 in both model derivation and validation sets. The correlation coefficients between the observed hepatocellular carcinoma risk and the nomogram-predicted risk were greater than 0.90 in all model derivation and validation sets. Conclusion These easy-to-use nomograms based on noninvasive clinical characteristics can accurately predict the risk of hepatocellular carcinoma in patients with chronic hepatitis B. They may facilitate risk communication between patients and clinicians.
引用
收藏
页码:2437 / 2444
页数:8
相关论文
共 50 条
  • [31] Renin-angiotensin system inhibitors and risk of hepatocellular carcinoma among patients with hepatitis B virus infection
    Chen, Ruixuan
    Zhou, Shiyu
    Liu, Jiao
    Li, Lu
    Su, Licong
    Li, Yanqin
    Fang, Chuyao
    Zhang, Xiaodong
    Luo, Fan
    Gao, Qi
    Lin, Yuxin
    Guo, Zhixin
    Cao, Lisha
    Xu, Xin
    Nie, Sheng
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2024, 196 (27) : E931 - E939
  • [33] Association of Physical Activity with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
    Chun, Ho Soo
    Park, Sojeong
    Lee, Minjong
    Cho, Yuri
    Kim, Ha Sung
    Choe, A. Reum
    Kim, Hwi Young
    Yoo, Kwon
    Kim, Tae Hun
    CANCERS, 2021, 13 (14)
  • [34] Risk calculators for hepatocellular carcinoma in patients affected with chronic hepatitis B in Asia
    Yang, Hwai-I
    Lee, Mei-Hsuan
    Liu, Jessica
    Chen, Chien-Jen
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (20) : 6244 - 6251
  • [35] Predictability of Liver-Related Seromarkers for the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients
    Lin, Yu-Ju
    Lee, Mei-Hsuan
    Yang, Hwai-I
    Jen, Chin-Lan
    You, San-Lin
    Wang, Li-Yu
    Lu, Sheng-Nan
    Liu, Jessica
    Chen, Chien-Jen
    PLOS ONE, 2013, 8 (04):
  • [36] Hepatitis B Virus Core Promoter Mutations in Patients With Chronic Hepatitis B and Hepatocellular Carcinoma in Bucharest, Romania
    Constantinescu, Ileana
    Dinu, Andrei-Antoniu
    Boscaiu, Voicu
    Niculescu, Marius
    HEPATITIS MONTHLY, 2014, 14 (10)
  • [37] Prognostic Value of Chronic Hepatitis B Virus Infection in Patients With Nasopharyngeal Carcinoma
    Liu, Xu
    Li, Xing
    Jiang, Ning
    Lei, Ying
    Tang, Ling-Long
    Chen, Lei
    Zhou, Guan-Qun
    Sun, Ying
    Yue, Dan
    Guo, Rui
    Mao, Yan-Ping
    Li, Wen-Fei
    Liu, Li-Zhi
    Tian, Li
    Lin, Ai-Hua
    Ma, Jun
    CANCER, 2014, 120 (01) : 68 - 76
  • [38] Hepatocellular carcinoma in noncirrhotic young adult patients with chronic hepatitis B viral infection
    Sezaki, H
    Kobayashi, M
    Hosaka, T
    Someya, T
    Akuta, N
    Suzuki, F
    Tsubota, A
    Suzuki, Y
    Saitoh, S
    Arase, Y
    Ikeda, K
    Kobayashi, M
    Matsuda, M
    Takagi, K
    Sato, J
    Kumada, H
    JOURNAL OF GASTROENTEROLOGY, 2004, 39 (06) : 550 - 556
  • [39] Hepatocellular carcinoma in noncirrhotic young adult patients with chronic hepatitis B viral infection
    Hitomi Sezaki
    Masahiro Kobayashi
    Tetsuya Hosaka
    Takashi Someya
    Norio Akuta
    Fumitaka Suzuki
    Akihito Tsubota
    Yoshiyuki Suzuki
    Satoshi Saitoh
    Yasuji Arase
    Kenji Ikeda
    Mariko Kobayashi
    Marie Matsuda
    Kimiko Takagi
    Junko Sato
    Hiromitsu Kumada
    Journal of Gastroenterology, 2004, 39 : 550 - 556
  • [40] Dynamic risk assessment for hepatocellular carcinoma in patients with chronic hepatitis C
    Lu, Mei
    Salgia, Reena
    Li, Jia
    Trudeau, Sheri
    Rupp, Loralee B.
    Wu, Trueman
    Daida, Yihe G.
    Schmidt, Mark A.
    Gordon, Stuart
    JOURNAL OF VIRAL HEPATITIS, 2023, 30 (09) : 746 - 755